Cargando…
Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine
Molecular targeted therapy has been developed for cancer chemoprevention and treatment. Cancer cells process a fundamental change in its bioenergetic metabolism from normal cells on an altered lipid metabolism, also known as the de novo fatty acid synthesis, for sustaining their high proliferation r...
Autores principales: | Cheng, Chien-shan, Wang, Zhiyu, Chen, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976840/ https://www.ncbi.nlm.nih.gov/pubmed/24778702 http://dx.doi.org/10.1155/2014/232946 |
Ejemplares similares
-
Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy
por: Wang, Zhiyu, et al.
Publicado: (2012) -
Drug Discovery Insights from Medicinal Beetles in Traditional Chinese Medicine
por: Deyrup, Stephen T., et al.
Publicado: (2021) -
Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL
por: Chi, Cheng, et al.
Publicado: (2022) -
Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma
por: Cao, Danfeng, et al.
Publicado: (2022) -
High content screening for drug discovery from traditional Chinese medicine
por: Wang, Jing, et al.
Publicado: (2019)